Norinchukin Bank The Has $3.78 Million Stock Position in CME Group Inc. (NASDAQ:CME)

Norinchukin Bank The grew its position in shares of CME Group Inc. (NASDAQ:CME) by 9.6% in the 4th quarter, HoldingsChannel reports. The fund owned 16,293 shares of the financial services provider’s stock after buying an additional 1,431 shares during the period. Norinchukin Bank The’s holdings in CME Group were worth $3,784,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the company. SJS Investment Consulting Inc. increased its holdings in CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 97 shares in the last quarter. New Age Alpha Advisors LLC boosted its position in shares of CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock valued at $30,000 after buying an additional 43 shares during the last quarter. Financial Life Planners bought a new stake in CME Group during the fourth quarter worth $32,000. Knuff & Co LLC purchased a new stake in CME Group in the 4th quarter valued at $33,000. Finally, Fortitude Family Office LLC lifted its stake in CME Group by 120.3% during the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after acquiring an additional 83 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have recently issued reports on CME shares. Raymond James upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 target price for the company in a research note on Monday, March 10th. Bank of America upped their price objective on shares of CME Group from $200.00 to $219.00 and gave the stock an “underperform” rating in a research report on Wednesday, April 2nd. Barclays lifted their target price on shares of CME Group from $263.00 to $279.00 and gave the stock an “equal weight” rating in a research report on Monday, April 7th. Piper Sandler upped their target price on CME Group from $275.00 to $283.00 and gave the company an “overweight” rating in a report on Tuesday, April 8th. Finally, JPMorgan Chase & Co. lifted their price target on CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a report on Thursday, February 13th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $247.47.

CME Group Price Performance

CME opened at $262.53 on Friday. The firm has a 50-day moving average price of $257.19 and a 200-day moving average price of $240.53. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $273.42. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The company has a market capitalization of $94.60 billion, a price-to-earnings ratio of 27.15, a PEG ratio of 6.76 and a beta of 0.43.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. Equities analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were issued a dividend of $1.25 per share. This is a boost from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date was Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a yield of 1.90%. CME Group’s dividend payout ratio is 51.71%.

Insider Buying and Selling

In other news, Director Howard J. Siegel sold 10,000 shares of the company’s stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $260.00, for a total value of $2,600,000.00. Following the transaction, the director now owns 21,873 shares of the company’s stock, valued at approximately $5,686,980. This represents a 31.37 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Suzanne Sprague sold 1,500 shares of CME Group stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total value of $385,245.00. Following the sale, the chief operating officer now directly owns 8,036 shares of the company’s stock, valued at $2,063,885.88. This represents a 15.73 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 27,076 shares of company stock valued at $6,871,496. Corporate insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.